CRL vs SNAL · rev $2.00B vs rev $81.2M
Charles River Laboratories (CRL) versus Snail, Inc. Class A Common Stock (SNAL) — a side-by-side from cached financials, not a winner call.
Charles River Laboratories (CRL) is a diagnostics & research company listed on US.
Snail, Inc. Class A Common Stock (SNAL) is a electronic gaming & multimedia company listed on NASDAQ.
Latest reported CRL revenue for 2026-06-27 was $2.00B. Net income was -$16.3M. CRL currently screens at market cap $7.78B.
Latest reported SNAL revenue for 2025-12-31 was $81.2M. Net income was -$27.2M. Revenue was down 3.8% from 2024-12-31 to 2025-12-31. SNAL currently screens at market cap $27.0M.
CRL currently screens at market cap $7.78B. SNAL currently screens at market cap $27.0M.
Not investment advice. Open the CRL and SNAL stock pages for the full models.
Not investment advice.